S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
Log in

NASDAQ:KRMD - Repro Med Systems Stock Price, Forecast & News

$6.82
-0.41 (-5.67 %)
(As of 02/24/2020 02:04 PM ET)
Today's Range
$6.75
Now: $6.82
$7.08
50-Day Range
$5.38
MA: $5.97
$7.27
52-Week Range
$1.38
Now: $6.82
$7.40
Volume6,452 shs
Average Volume166,800 shs
Market Capitalization$269.39 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.3
Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KRMD
CUSIPN/A
CIKN/A
Phone845-469-2042

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.35 million
Cash Flow$0.03 per share
Book Value$0.23 per share

Profitability

Net Income$910,000.00

Miscellaneous

Employees75
Market Cap$269.39 million
Next Earnings Date2/25/2020 (Estimated)
OptionableNot Optionable

Receive KRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.


Repro Med Systems (NASDAQ:KRMD) Frequently Asked Questions

What is Repro Med Systems' stock symbol?

Repro Med Systems trades on the NASDAQ under the ticker symbol "KRMD."

How were Repro Med Systems' earnings last quarter?

Repro Med Systems (NASDAQ:KRMD) announced its quarterly earnings results on Tuesday, November, 5th. The company reported $0.02 earnings per share (EPS) for the quarter. The business earned $6.62 million during the quarter. Repro Med Systems had a return on equity of 9.93% and a net margin of 1.37%. View Repro Med Systems' Earnings History.

When is Repro Med Systems' next earnings date?

Repro Med Systems is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Repro Med Systems.

Has Repro Med Systems been receiving favorable news coverage?

Media headlines about KRMD stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Repro Med Systems earned a coverage optimism score of 1.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Repro Med Systems.

Are investors shorting Repro Med Systems?

Repro Med Systems saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 299,900 shares, an increase of 41.3% from the January 15th total of 212,300 shares. Based on an average daily trading volume, of 191,100 shares, the days-to-cover ratio is presently 1.6 days. Approximately 0.9% of the company's stock are sold short. View Repro Med Systems' Current Options Chain.

Who are some of Repro Med Systems' key competitors?

What other stocks do shareholders of Repro Med Systems own?

Who are Repro Med Systems' key executives?

Repro Med Systems' management team includes the folowing people:
  • Mr. Donald B. Pettigrew, CEO, Pres & Chief Commercial Officer (Age 51)
  • Ms. Karen Fisher, CFO, Treasurer & Corp. Sec. (Age 53)
  • Mr. Manuel A. Marques, Chief Operating Officer (Age 46)
  • Mr. Craig S. Ross, VP of Sales & Marketing

How do I buy shares of Repro Med Systems?

Shares of KRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Repro Med Systems' stock price today?

One share of KRMD stock can currently be purchased for approximately $6.83.

How big of a company is Repro Med Systems?

Repro Med Systems has a market capitalization of $269.79 million and generates $17.35 million in revenue each year. Repro Med Systems employs 75 workers across the globe.View Additional Information About Repro Med Systems.

What is Repro Med Systems' official website?

The official website for Repro Med Systems is http://www.rmsmedicalproducts.com/.

How can I contact Repro Med Systems?

Repro Med Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company can be reached via phone at 845-469-2042 or via email at [email protected]


MarketBeat Community Rating for Repro Med Systems (NASDAQ KRMD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  10 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  20
MarketBeat's community ratings are surveys of what our community members think about Repro Med Systems and other stocks. Vote "Outperform" if you believe KRMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KRMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel